Testing a program to screen for sickle cell disease and prevent violence during pregnancy in India
Pilot-testing and Implementation of an Integrated Sickle-cell Screening and Violence Prevention Program in Antenatal Care Settings in India (PIVOT)
This study is looking at how to help pregnant women in India by combining sickle cell disease screening with support for those who might face partner violence after getting their results, to ensure they feel safe and cared for.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10808507 on NIH RePORTER |
What this research studies
This research aims to implement a program that integrates sickle cell disease screening with violence prevention efforts in antenatal care settings in India. It focuses on pregnant women who may be at risk of intimate partner violence after receiving their sickle cell screening results. The program uses a simple solubility test to identify women with sickle cell trait or disease, followed by further testing to confirm their status. The study will also explore the relationship between receiving these results and the risk of experiencing violence from partners.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women in India who are undergoing antenatal care and may be at risk for sickle cell disease or trait.
Not a fit: Patients who are not pregnant or those who do not have access to antenatal care in India may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could improve the health outcomes of pregnant women by providing timely screening for sickle cell disease and reducing the risk of intimate partner violence.
How similar studies have performed: Previous research has indicated that integrating health screenings with violence prevention strategies can be effective, suggesting potential success for this approach.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Halim, Nafisa — Boston University Medical Campus
- Study coordinator: Halim, Nafisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.